查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗菌药物敏感性测试市场规模、份额和成长分析（按产品、类型、方法、应用、最终用户和地区划分）—2026-2033年产业预测
市场调查报告书
商品编码
1895944

抗菌药物敏感性测试市场规模、份额和成长分析（按产品、类型、方法、应用、最终用户和地区划分）—2026-2033年产业预测

Antimicrobial Susceptibility Testing Market Size, Share, and Growth Analysis, By Product, By Type, By Method, By Application, By End User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年，抗生素敏感性测试市场规模将达到 46.3 亿美元，到 2025 年将达到 48.7 亿美元，到 2033 年将达到 73.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 5.2%。

抗菌药物敏感性检测 (AST) 市场在医疗保健领域发挥着至关重要的作用，尤其是在感染疾病控制和微生物学发展方面。其主要驱动因素包括抗生素抗药性细菌的日益普及和全球感染疾病的快速增长，这些因素推动了对精准诊断技术的需求。自动化和分子方法等创新正在提高 AST 的准确性和有效性。不断涌现的市场参与企业也为医疗保健机构提供了多样化的检测选择。然而，AST 技术高成本、缺乏标准化以及操作流程复杂等挑战，尤其是在低收入地区，可能会阻碍市场成长。儘管如此，就地检验)的兴起和再生医学的进步正在为更方便的 AST 解决方案和市场扩张创造机会。

抗菌药物敏感性测试市场驱动因素

抗菌药物抗药性（AMR）问题日益严重，已成为全球重大的健康威胁，促使卫生组织和监管机构将可靠的抗菌药物敏感性试验（AST）作为优先事项，以监测抗药性趋势。这项工作有助于制定治疗策略并促进合理使用抗生素。此外，由于旅行增加、都市化和人口增长等因素，感染疾病病例不断增加，凸显了高效诊断和治疗方法方案的迫切需求。因此，人们越来越需要有效可靠的抗菌药物敏感性试验解决方案，以应对抗药性病原体带来的威胁，并确保患者照护。

限制抗菌药物敏感性测试市场的因素

在某些地区，尤其是在中低收入国家，人们对抗菌药物敏感性试验（AST）的益处普遍缺乏认识。此外，实验室技术人员在现代检测技术方面的训练不足也会阻碍AST实务的有效实施。同时，诊断设备和解决方案的监管环境复杂且耗时，为创新的AST技术及时上市带来了挑战。严格的监管要求会进一步加剧这些延误，并最终限制受影响地区重要AST调查方法的可近性和应用。

抗菌药物敏感性测试市场趋势

抗菌药物敏感性检测市场的一个显着趋势是快速检测技术的应用，这些技术能够显着缩短获得检测结果所需的时间。质谱分析、分子诊断和自动化系统等技术正引领这项变革，使医疗服务提供者能够快速识别病原体及其药物敏感性谱。这项进步在急诊护理环境中尤其重要，因为及时介入能够显着改善患者的预后。随着医疗机构越来越重视治疗决策的效率和准确性，对快速抗菌药物敏感性检测解决方案的需求预计将会成长，从而推动该领域的创新和投资。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究分析
  • 专利分析

全球抗菌药物敏感性测试市场规模（按产品和复合年增长率划分）（2026-2033 年）

  • 消耗品
    • 培养基
    • 磁化率测试盘
    • MIC 试纸
    • 药敏试验平板
  • 实验设备
    • 自动化实验室设备
    • 分子诊断系统
  • 实验室耗材

全球抗菌药物敏感性测试市场规模（按类型和复合年增长率划分）（2026-2033 年）

  • 抗菌药物敏感性试验
  • 抗真菌药物敏感性试验
  • 抗寄生虫药物敏感性试验
  • 抗病毒药物敏感性试验

全球抗菌药物敏感性测试市场规模（按方法和复合年增长率划分）（2026-2033 年）

  • 定性方法
    • 自动化AST方法
    • 纸锭扩散法
    • 琼脂稀释法
    • 基因分型方法
  • 定量方法
    • ETEST 方法
    • 肉汤微量稀释法

全球抗菌药物敏感性测试市场规模（按应用领域及复合年增长率划分）（2026-2033 年）

  • 临床诊断
  • 药物发现与开发
  • 流行病学
  • 其他用途

全球抗菌药物敏感性测试市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

  • 医院和诊断中心
  • 製药和生物技术公司
  • 学术和研究机构
  • 临床研究所

全球抗菌药物敏感性测试市场规模（按地区划分）及复合年增长率（2026-2033 年）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Thermo Fisher Scientific Inc.（US）
  • Bio-Rad Laboratories, Inc.（US）
  • Danaher Corporation（US）
  • Becton, Dickinson and Company（US）
  • bioMerieux SA（France）
  • Roche Diagnostics（Switzerland）
  • Abbott Laboratories（US）
  • Bruker Corporation（US）
  • Merck KGaA（Germany）
  • Agilent Technologies, Inc.（US）
  • ConvaTec Group plc（UK）
  • HiMedia Laboratories Pvt. Ltd.（India）
  • Liofilchem srl（Italy）
  • Accelerate Diagnostics, Inc.（US）
  • Creative Diagnostics（US）
  • Bio-Rad Laboratories（US）
  • Synbiosis（UK）
  • QIAGEN NV（Germany）

结论与建议

简介目录
Product Code: SQMIG35B2120

Antimicrobial Susceptibility Testing Market size was valued at USD 4.63 Billion in 2024 and is poised to grow from USD 4.87 Billion in 2025 to USD 7.31 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The antimicrobial susceptibility testing (AST) market is integral to healthcare, particularly in managing infectious diseases and advancing microbiology. Driving factors include the escalating prevalence of antibiotic-resistant bacteria and a global surge in infectious diseases, which heightens the demand for accurate diagnostic technologies. Innovations like automation and molecular methods are enhancing AST precision and effectiveness. The growing number of market players also presents diverse testing options for healthcare providers. However, challenges such as high costs of AST technologies, lack of standardization, and procedural complexities may hinder market growth, particularly in lower-income regions. Nonetheless, the increasing trend towards point-of-care testing, along with advancements in regenerative medicine, opens opportunities for more user-friendly AST solutions and market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Antimicrobial Susceptibility Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Antimicrobial Susceptibility Testing Market Segments Analysis

Global Antimicrobial Susceptibility Testing Market is segmented by Product, Type, Method, Application, End User and region. Based on Product, the market is segmented into Consumables, Lab Instruments and Lab Disposables. Based on Type, the market is segmented into Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing and Antiviral Susceptibility Testing. Based on Method, the market is segmented into Qualitative Methods and Quantitative Methods. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Epidemiology and Other Applications. Based on End User, the market is segmented into Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Clinical Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Antimicrobial Susceptibility Testing Market

The escalating issue of antimicrobial resistance (AMR) poses a significant challenge to global health, prompting health organizations and authorities to prioritize robust antimicrobial susceptibility testing (AST) to monitor resistance trends. This focus aids in informing treatment strategies and promoting prudent antibiotic usage. Additionally, the rise in infectious disease cases, fueled by elements such as increased travel, urbanization, and population growth, underscores the urgent need for efficient diagnosis and treatment options. Consequently, there is a heightened demand for effective and dependable AST solutions to combat the threats posed by resistant pathogens and ensure optimal patient care.

Restraints in the Antimicrobial Susceptibility Testing Market

In certain regions, particularly middle-income and low-income countries, there is a significant lack of awareness regarding the advantages of Antimicrobial Susceptibility Testing (AST). Additionally, inadequate training for laboratory personnel in the latest testing techniques can hinder the effective implementation of AST practices. Furthermore, the regulatory landscape concerning diagnostic instruments and solutions can be intricate and time-consuming, leading to challenges in the timely market introduction of innovative AST technologies. Stringent regulatory requirements may further exacerbate these delays, ultimately limiting the accessibility and utilization of essential AST methodologies in affected regions.

Market Trends of the Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing market is witnessing a notable trend toward the adoption of rapid testing techniques that significantly reduce the time needed to obtain results. Technologies such as mass spectrometry, molecular diagnostics, and automated systems are at the forefront of this transformation, enabling healthcare providers to swiftly identify pathogens and their susceptibility profiles. This advancement is particularly critical in urgent care scenarios, where timely interventions can greatly enhance patient outcomes. As healthcare environments increasingly prioritize efficiency and precision in treatment decisions, the demand for rapid testing solutions in antimicrobial susceptibility is expected to expand, driving innovation and investment in this sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Study Analysis
  • Patent Analysis

Global Antimicrobial Susceptibility Testing Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Consumables
    • Culture & Growth Media
    • Susceptibility Testing Disks
    • Mic Strips
    • Susceptibility Testing Plates
  • Lab Instruments
    • Automated Laboratory Instruments
    • Molecular Diagnostics Systems
  • Lab Disposables

Global Antimicrobial Susceptibility Testing Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Antibacterial Susceptibility Testing
  • Antifungal Susceptibility Testing
  • Antiparasitic Susceptibility Testing
  • Antiviral Susceptibility Testing

Global Antimicrobial Susceptibility Testing Market Size by Method & CAGR (2026-2033)

  • Market Overview
  • Qualitative Methods
    • Automated Ast
    • Disk Diffusion
    • Agar Dilution
    • Genotypic Method
  • Quantitative Methods
    • ETEST Method
    • Broth Macrodilution

Global Antimicrobial Susceptibility Testing Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Clinical Diagnostics
  • Drug Discovery & Development
  • Epidemiology
  • Other Applications

Global Antimicrobial Susceptibility Testing Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Clinical Research Organizations

Global Antimicrobial Susceptibility Testing Market Size & CAGR (2026-2033)

  • North America (Product, Type, Method, Application, End User)
    • US
    • Canada
  • Europe (Product, Type, Method, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Type, Method, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Type, Method, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Type, Method, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiMedia Laboratories Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Liofilchem s.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accelerate Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synbiosis (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V. (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations